drugset / Trial / NCT05772676
The Effect of Aprepitant Reducing Postoperative Nausea and Vomiting
RandomizedParallel-groupTriple-blindPrevention
Summary
The purpose of this study is to assess the efficacy of Aprepitant + standard antiemetic regimen in reducing postoperative nausea and vomiting after laparoscopic gastric sleeve versus placebo + standard antiemetic regimen
Timeline
- Start
- 2022-12-01
- Primary completion
- 2023-01-01
- Completion
- 2023-04-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aprepitant | Other / unclassified | 80 mg | Oral |
| Subject | Aprepitant | Other / unclassified | 125 mg | Oral |